Lynparza tablets approved for NHS use in platinum-sensitive, BRCA-mutated ovarian, fallopian tube or peritoneal cancer
January 16, 2020Sales and Marketing AstraZeneca, MSD, NHS, NICE, UK, lynparza
It has been announced that tablet form of Lynparza (olaparib), the PARP inhibitor developed by AstraZeneca and MSD, has secured …
US-China trade deal sees changes on drug patents
January 16, 2020Business Services China, Chinese Drug Patents, Trade Deal, US Drug Patents, US-China Trade Deal
The US and China signed the first part of a broader trade pact that included setting up a system to …
AbbVie’s Skyrizi outpaces Novartis’ Cosentyx in plaque psoriasis skin clearance
January 16, 2020Research and Development AbbVie, Cosentyx, Novartis, Skyrizi, pharma, psoriasis
AbbVie has made it known that Skyrizi (risankizumab) outpaced Novartis’ Cosentyx (secukinumab) at Phase 3 in the treatment of plaque …
HIV infections fall by 73% in bi and gay British men
January 16, 2020Business Services AIDS, AIDS Epidemic, HIV, NHS, NHS England, PrEP, nhs scotland
Public Health England has released figures that show that HIV rates in bi and gay men have fallen by 73% …
NICE shoots down Keytruda in head and neck cancer over data concerns
January 16, 2020Sales and Marketing Cancer, NHS, NICE, UK, keytruda, pharma
It has been revealed that NICE has chosen to reject MSD’s blockbuster immunotherapy Keytruda (pembrolizumab) for routine use on the …
FDA approves Lannett’s cocaine-based nasal spray
January 15, 2020Research and Development FDA, Lannett, Numbrino, cocaine
It has been announced that the FDA has moved to approve Lannett Company’s Numbrino (cocaine hydrochloride) nasal solution for “the …
FDA panel votes against Nektar opioid painkiller
January 15, 2020Research and Development Bernie Opioids, Big Pharma, Trump opioids, opioid, opioid crisis, opioids, pharma
FDA unanimously voted against Nektar Therapeutics opioid pankiller (NKTR-181) for chronic lower back pain, prompting the company to withdraw its …
Pfizer’s Ibrance combo authorised via the Cancer Drugs Fund for advanced breast cancer
January 15, 2020Research and Development Cancer Drugs Fund, NICE, Pfizer, ibrance, pharma
NICE, the drug watchdog for England and Wales, has given its approval for Pfizer’s Ibrance (palbociclib) in combination with AstraZeneca’s …
Rochester Drug Cooperative ceases opioid sales following criminal charges
January 15, 2020Research and Development Bernie Sanders, Trump opioids, opioid, opioid crisis, opioids
The Rochester Drug Cooperative (RDC) has announced it will no longer distribute opioid medications after two of its executives were …
Democrat Presidential Candidates pledge to lower drug prices without Congress’ help
January 15, 2020Research and Development Bernie Sanders, GOP, Trump, US President, US Presidential Election, democrats, republican
Two Democratic presidential candidates said that if they are elected president they will act immediately to reduce the cost of …
Chinese coronavirus found in Thailand
January 14, 2020Manufacturing and Production China, WHO, World Health Organisation, Wuhan, pneumonia, thailand
The recent viral pneumonia outbreak in Wuhan China has spread to Thailand.The patient is a 61 year old woman who …
MorphoSys and Incyte forge potential $1.1bn partnership to develop B cell malignancy drug candidate
January 14, 2020Manufacturing and Production, Sales and Marketing Incyte, morphosys, pharma, tafasitamab
MorphoSys and Incyte have joined together in a partnership to develop and commercialise the latter’s anti-CD19 antibody tafasitamab as a …
Acasti’s shares plunge as new drug does not meet primary endpoint
January 14, 2020Manufacturing and Production Acasti, Acasti Pharma, CaPre, Primary Endpoint, Shares
Acasti Pharma’s shares plunged by as much as 67% this week as its drug CaPre failed to meet its primary …
Biogen picks up Pfizer’s Phase 1 therapy for Alzheimer’s symptoms in potential $700m deal
January 14, 2020Manufacturing and Production, Sales and Marketing Alzheimer's, Biogen, Pfizer, pharma
Biogen has entered into an agreement with Pfizer to acquire the latter’s Phase 1 candidate PF-05251749 in order to develop …
NHS to pioneer Novartis injection that reduces cholesterol
January 14, 2020Manufacturing and Production NHS, NHS England, bad cholesterol, cholesterol, heart attack
The NHS in England is pioneering a new twice-a-year injection, inclisiran, which reduces bad cholesterol.It has reached a deal with …
NHS Scotland recommends Janssen’s Zytiga combo for newly diagnosed prostate cancer
January 13, 2020Sales and Marketing Cancer, NHS, Scotland, nhs scotland, prostate cancer
Janssen’s Zytiga (abiraterone acetate) has just been approved by the Scottish Medicines Consortium (SMC), meaning that male patients on the …
Working Life Interview: Jean-Paul Kress, CEO of MorphoSys
January 13, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Working Life, feature, morphosys, pharma
With a medical doctorate as well as degrees in pharmacology and immunology under your belt, was your path always to …
FDA approves Astellas injectable antifungal drug for newborns
January 13, 2020Sales and Marketing Astellas, Atellas Pharma, FDA, fungal virsus
The FDA has approved the first antifungal drug to specifically treat invasive candidiasis in newborns. From Astellas, the new drug …
Eli Lilly to boost immunology portfolio with $1.1bn Dermira acquisition
January 13, 2020Sales and Marketing Dermira, Eli Lilly, pharma
Eli Lilly has announced it has entered into an agreement to acquire Dermira, a biopharmaceutical firm focused on the development …
Pakistan registers cases against 200 pharmaceutical companies
January 13, 2020Sales and Marketing National Task Force, Pakistan, Pakistani Pharmaceuticals, corruption
The Punjab Quality Control Board has sent at least 74 cases to the drugs courts for prosecution, and has overall …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
